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Abstract
Objectives: In this work we investigated the effect of the consumption of the Mediterranean diet
on coronary risk, in subjects with the metabolic syndrome.
Methods: During 2000–2002, we randomly selected, from all Greek regions, 848 hospitalised
patients (695 males, 58 ± 10 & 153 females, 65 ± 9 years old) with a first event of acute coronary
syndrome and 1078 frequency matched, by sex, age, region controls, without any suspicious for
cardiovascular disease. Nutritional habits were evaluated through a validated questionnaire, while
the metabolic syndrome was defined according to the NCEP ATP III criteria. Mediterranean diet
was defined according to the guidelines of the Division of Nutrition/Epidemiology, of Athens
Medical School.
Results: Of the 1926 participants, 307 (36.2%) of the patients and 198 (18.4%) of the controls (P
< 0.001) met the ATP III criteria. This was related with 2fold adjusted coronary risk (odds ratio =
2.35, 95% 1.87 – 2.84) in subjects with the metabolic syndrome as compared with the rest of them.
No differences were observed concerning the prevalence of the metabolic syndrome and sex of
subjects, after adjustment for group of study (P > 0.1). Eighty (26%) of the patients and 70 (35%) of
the controls (P < 0.01) with the metabolic syndrome were "closer" to the Mediterranean diet.
Multivariate analysis revealed that the adoption of this diet is associated with a 35% (odds ratio =
0.65, 95% 0.44 – 0.95) reduction of the coronary risk in subjects with the metabolic syndrome, after
adjusting for age, sex, educational and financial level and the conventional cardiovascular risk
factors.
Conclusion: Consequently, the adoption of Mediterranean diet seems to attenuate the coronary
risk in subjects with the metabolic syndrome.
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Background
The metabolic syndrome is a condition that promotes
atherosclerosis and increases the risk of cardiovascular
events [1–3]. According to the Centers for Disease Control
and Prevention, at least 47 million Americans, or about
one in five people, have this condition [1]. Contributors
to the development of the metabolic syndrome may in-
clude genetics, a sedentary lifestyle, a Western diet (high
in refined carbohydrates, low in fiber, and high in saturat-
ed fat), cigarette smoking, and progressive weight gain [2].
The characteristics of the metabolic syndrome include
atherogenic dyslipidemia, a prothrombotic state, insulin
resistance, hypertension, and abdominal obesity [3,4].
Each abnormality promotes atherosclerosis independent-
ly, but when clustered together, these metabolic disorders
are increasingly atherogenic and enhance the risk of cardi-
ovascular morbidity and mortality [1]. Based on observa-
tional studies there is evidence to support that several
factors related to lifestyle habits may influence cardiovas-
cular risk [5–7]. Among these factors the beneficial effect
of several dietary patterns on human health, have already
been underlined [8–10]. One of these diets, the Mediter-
ranean diet, has received much attention during the past
decades. It is reach in non-refined cereals, fruits and vege-
tables, and it has a high monounsaturated: saturated fat
ratio. Although the benefits from the adoption of this diet
on all cause survival have long been recognized, little is
known about its association with the development of
acute coronary events, in people with the metabolic syn-
drome. In this work, we evaluated the effect of the adop-
tion of Mediterranean diet on the risk of developing non-
fatal acute coronary events, in subjects with metabolic
syndrome.
Materials and Methods
Study's population
The CARDIO2000 is a multicentre case-control study that
investigates the association between several demographic,
nutritional, lifestyle and medical risk factors with the risk
of developing non-fatal acute coronary syndromes. From
January 2000 to August 2001, 848 individuals who had
just entered to the hospital for a first event of coronary
heart disease (stable angina was excluded from the analy-
sis) agreed to participate into the study (response rate
89%). Six hundred fifty-eight (77%) of them were males
(59.0 ± 10 years old) and 190 (23%) were females (65.3
± 9 years old). The inclusion criteria for cardiac patients
are:
• First event of acute myocardial infarction diagnosed by
two or more of the following features: typical electrocardi-
ographic changes, compatible clinical symptoms, specific
diagnostic enzyme elevations, or
• First diagnosed unstable angina corresponding to class
III of the Braunwald classification.
Moreover, 1078 randomly selected cardiovascular disease
free subjects (controls), frequency matched to the patients
by age (± 3 years), sex, and region agreed to participate
(response rate 83%). Eight hundred and thirty (77%) of
them were males (58.0 ± 10 years old) and 248 (23%)
were females (64.8 ± 9 years old). Controls were individ-
uals who visited the outpatients departments of the same
hospital and at the same period with the coronary patients
for minor surgical operations. All the controls were sub-
jects without any clinical symptoms, signs or any suspi-
cion of cardiovascular disease in their medical history, as
a physician evaluated it. We used this type of controls in
order to have more accurate medical information, to elim-
inate the potential adverse effect of several, unknown,
confounders and to increase the likelihood that cases and
controls share the same study base [11]. The number of
the participants was decided through power analysis, in
order to evaluate differences in the coronary relative risk
greater than 7% (statistical power > 0.80, significant level
< 0.05).
Stratification
According to the population distribution provided by the
National Statistical Services (census 2000), we stratified
our sampling into all the Greek regions, in order to in-
clude various socio-economical levels and cultural partic-
ularities of the investigated population. The enrolled
subjects are from, approximately, the one half of the clin-
ics, public or private, of the two biggest metropolitan cit-
ies (Athens and Thessalonica), and from, almost, all the
major clinics of the other regions (3 from Sterea Ellada, 3
from Thessalia, 2 from Hpeiros, 5 from Macedonia, 2
from Thrace, 5 from Peloponnese, 2 from Crete, 5 from
Aegean and 3 from Ionian islands).
Randomised procedure
In order to reduce the unbalanced distribution of several
measured or unmeasured confounders, both patients and
controls were randomly selected. Thus, a sequence of ran-
dom numbers (1...0) was applied in the hospitals' admis-
sion listings. The coronary patients who assigned to the
number 1 were entered into the study and interviewed
(i.e. approximately the one half of the cardiac patients
that visited each cardiology clinic). The same procedure
was applied for the controls, after taking into account the
matching criteria.
Investigated parameters
A specialist retrieved the information regarding the inves-
tigated medical factors from the subjects' medical records,
and the information regarding the life style characteristics
through a confidential questionnaire during a specificNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/1
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interview after the 2nd day of the hospitalisation, for the
cases and at entry for the controls. The evaluation of the
nutritional habits was based on a nutrient questionnaire
according to the guidelines from the Department of Nutri-
tion of the National School of Public Health [12]. The
Mediterranean dietary pattern consists of: (a) daily con-
sumption: of non refined cereals and products (whole
grain bread, pasta, brown rice, etc), vegetables (2 – 3 serv-
ings/day), fruits (6 servings/day), olive oil (as the main
added lipid) and dairy products (1 – 2 servings/day), (b)
weekly consumption: of fish (4–5 servings/week), poultry
(3 – 4 servings/week), olives, pulses, and nuts (3 servings/
week), potatoes, eggs and sweets (3 – 4 servings/week)
and monthly consumption: of red meat and meat prod-
ucts (4 – 5 servings/month). It is, also, characterized by
moderate consumption of wine (1 – 2 wineglasses/day)
and high monounsaturated: saturated fat ratio (> 2). This
dietary pyramid was suggested by a Harvard-led group
with substantial input from Greek scientists [13]. Thus, we
measured the consumption of these food items as an av-
erage per week, during the past year. Then, the frequency
of consumption was quantified approximately in terms of
the number of times a month the food was consumed.
The weekly consumption multiplied by 4 and a value of 0
was assigned to food items rarely or never consumed. In
order to describe total diet we used composite scores,
which are necessary for the evaluation of epidemiological
associations [12]. We defined subjects who are "closer" to
the Mediterranean type of diet using as cut-off points the
median values of the monthly food consumption score as
done by several investigators in the past [12]. Finally, al-
cohol consumption was measured by daily ethanol in-
take, in wineglasses (100 ml of 12% ethanol
concentration).
According to the collected medical information, the ma-
jority of the controls (86%) and of the patients (83%) had
at least one-laboratory measurement during the past 12
months. In addition, we measured, both in patients and
controls, arterial blood pressure levels (average of 3 meas-
urements with subject sited and calm for at least 30 min-
utes; using a standard sphygmomanometer. Fast total
cholesterol as well as fast blood glucose levels were meas-
ured in serum. For the cardiac patients the measurements
were collected during the first 12 hours of hospitalisation,
and for the controls at the end of the interview. The previ-
ous information as well as the patients' and controls' re-
ports assisted us to characterize the subjects as
hypertensive, hypercholesterolemic and diabetics. In par-
ticular, in keeping with the long-standing classification
criteria used in several epidemiological studies [2], pa-
tients who reported never having been told of having hy-
pertension and were not currently taking any
antihypertensive medication and whose blood pressure
was less than 140 / 90 mmHg were classified as normo-
tensives. Patients whose mean blood pressure levels were
greater or equal to 140 / 90 mmHg or were under antihy-
pertensive medication were classified as hypertensives.
Hypercholesterolemia was defined, as cholesterol levels
greater than 220 mg/dl or greater than 200 mg/dl when
two other risk factors for coronary heart disease or use of
special hypo-lipidemic treatment was present. Diabetics
were those with fast blood glucose greater than 125 mg/dl
or were under special diet or treatment. Finally, we meas-
ured the height and the weight both in patients and con-
trols. In addition, we marked any significant changes in
their body mass occurred during the past years. Thus,
obesity was defined as body mass index (weight /
{height}  2) greater than 29.9 Kg/m2. Current smokers
were defined those who smoked at least one cigarette per
day. Quantification of smoking status was based on the
calculation of pack-years adjusted for nicotine contain-
ment equal to 0.8-mgr per cigarette. Former smokers were
defined as the subjects who stopped smoking for over 1
year. Physical activity was defined as any type of leisure
time exercise or occupational activity, at least 1/week dur-
ing the past year, and was gradated in qualitative terms
such as light (expended calories < 4 Kcal/ min, i.e. walking
slowly, cycling stationary, light stretching etc.), moderate
(expanded calories 4–7 Kcal/ min, i.e. walking briskly, cy-
cling outdoor, swimming moderate effort etc.) and vigor-
ous (expanded calories >7 Kcal/ min, i.e. walking briskly
uphill, long distance running, cycling fast or racing, swim-
ming fast crawl etc.) [20]. The rest of the subjects were de-
fined as physically inactive. Also, the intension and the
duration of physical exercise were taken into account.
Subject's educational level was measured and classified
into three groups: Group I, up to high school (or < 9 years
of schooling); Group II, high school, technical school (or
9 – 14 years of eschooling) but not university and Group
III, university. Mean annual income, during the past 5
years was, also, recorded. Further details regarding the de-
sign and methodology of the CARDIO2000 study have
been previously presented [14,15].
As previously mentioned in this work we focused our in-
terest in people with the metabolic syndrome. According
to ATP III [2], the diagnosis of metabolic syndrome was
established if 3 or more of the following risk factors were
present:
• waist circumference >102 cm (40 in) for men or >88 cm
(37 in) for women;
• triglyceride level >150 mg/dL;
• HDL cholesterol level <40 mg/dL for men or <50 mg/dL
for women;
• blood pressure >130/85 mm Hg;Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/1
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• or fasting glucose >110 mg/dL.
Statistical analysis
Continuous variables are presented as mean ± one stand-
ard deviation while qualitative variables are presented as
absolute and relative frequencies. In order to fit multivar-
iate risk models an exploratory analysis was initially ap-
plied. Contingency tables with calculation of chi-squared
test, as well as the calculation of Student's t-test were ap-
plied for the evaluation of the associations between the
categorical and continuous variables with the outcome.
Estimations of the relative risks of developing acute coro-
nary syndromes, under several hypotheses, were per-
formed by the calculation of the odds ratio (OR) and the
corresponding confidence intervals through multiple lo-
gistic regression analysis, with stepwise elimination pro-
cedure. All reported P-values are based on two-sided tests
and compared to a significant level of 5%. STATA 6 soft-
ware was used for the calculations (STATA Corp. College
Station, Texas, USA).
Results
Descriptive analysis
Three hundred and seven (36.2%) of the patients and 198
(18.4%) of the controls (P < 0.001) met the ATP III crite-
ria. The metabolic syndrome was more frequent in males'
than in females' controls (22% vs. 10.4%, p < 0.001),
while no statistically significant differences were found re-
garding the prevalence of the metabolic syndrome among
male and female coronary patients (37% vs. 33%, p =
0.420). About the one half of the controls and 60% of the
patients with the metabolic syndrome reported sedentary
life (p = 0.240). Current smoking habits were highly asso-
ciated with the prevalence of the metabolic syndrome, on
both, patients and controls (p < 0.001). A consistent in-
verse association was observed between the prevalence of
the metabolic syndrome and the financial status of pa-
tients (p for trend = 0.598) and controls (p for trend =
0.001). No associations were observed regarding the pres-
ence of the metabolic syndrome and the educational pro-
file of the patients (p = 0.280) and the controls (p =
0.136). Focusing our interest on the consumption of Med-
iterranean diet we observed that 80 (26%) of the patients
and 70 (35%) of the controls (p < 0.01) that fulfilled the
criteria for the metabolic syndrome were "closer" to the
Mediterranean diet. Table 1 presents the prevalence of hy-
pertension, hypercholesterolemia, diabetes mellitus,
physical inactivity, obesity and smoking habits, in pa-
tients and controls that adopted the Mediterranean diet
compared to patients and controls that they did not adopt
this diet. These associations raise the confounding effect
of the adoption of the Mediterranean diet on obesity,
physical activity and smoking habits. Moreover, both pa-
tients and controls that were defined "closer" to the Med-
iterranean diet had lower prevalence of the conventional
cardiovascular risk factors compared to the rest of the sub-
jects (Table 1).
Risk stratification
Multivariate analysis revealed that the metabolic syn-
drome 2fold the coronary risk (odds ratio = 2.35, 95%
1.87 – 2.84) after adjustment for age, sex, physical activity
levels, smoking habits, financial status and presence of hy-
pertension, hypercholesterolemia, and diabetes mellitus.
However, the unadjusted odds ratio for developing an
acute coronary event in people who adopted the Mediter-
ranean diet was 0.64 (95% CI 0.44 – 0.95), indicating a
36% reduction of the coronary risk as compared with peo-
ple that did not adopt this diet. After taking into account
the effect of the aforementioned associations (descriptive
analysis) as well as the effect of several potential
confounders, like age and sex of the participants, systolic
and diastolic blood pressures, total serum cholesterol and
blood glucose levels, as well as premature family history
Table 1: Prevalence of the conventional cardiovascular risk factors in coronary patients and controls with the metabolic syndrome, 
stratified by the main factor of interest, i.e. adoption of the Mediterranean diet and physically active lifestyle or not
Mediterranean diet No Mediterranean diet P-value
Patients Controls Patients Controls
Current smoking 42 (53%) 29 (41%) 156 (69%) 51 (40%) 0.085
Physical inactivity 49 (61%) 33 (47%) 136 (60%) 64 (50%) 0.124
Hypertension 50 (63%) 23 (33%) 133 (59%) 51 (41%) < 0.001
Hypercholesterolemia 47 (59%) 12 (17%) 145 (64%) 26 (20%) < 0.001
Obesity 33 (41%) 15 (24%) 63 (28%) 31 (28%) 0.324
Diabetes mellitus 30 (38%) 10 (15%) 79 (35%) 23 (18%) 0.001
Last column represents the pooled probability value (p-value) that is derived from the cross – tabulated comparisons between group of the study 
(patients – controls) and the classical cardiovascular risk factors, stratified by the main factor of interest (i.e. combination of Mediterranean diet and 
physical activity or not).Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/1
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of coronary heart disease, we found that effect of the con-
sumption of Mediterranean diet on the coronary risk re-
mains beneficial. In particular, the adoption of this diet is
associated with a 23% (odds ratio = 0.77, Table 2) reduc-
tion of the coronary risk in subjects with the metabolic
syndrome. The calculated attributable risk by the formula:
attributable risk = (odds ratio – 1) / odds ratio [11], sug-
gested that the one third (30%) of the acute coronary
events could be prevented by the adoption of the Mediter-
ranean diet, in subjects with the metabolic syndrome.
Moreover, the adoption of Mediterranean diet by people
who reported that they exercise at least once per week (>
4 kcal/min) seems to have an additive benefit, since it is
associated with 47% (odds ratio = 0.53, P < 0.01) lower
risk of developing acute coronary events, after adjusting
for age, sex, and the levels of the common cardiovascular
risk factors. This reduction of the coronary risk is much
higher than Mediterranean diet or exercise (odds ratio =
0.89, p < 0.05) achieve alone in this group of people.
Discussion
In this work we evaluated the effect of the adoption of
Mediterranean diet on the development of acute coronary
syndromes, in subject with the metabolic syndrome. The
data analysis revealed that the adoption of the Mediterra-
nean diet is associated with a considerable reduction of
the coronary risk, in these people, after adjustment for
several potential confounders.
The metabolic syndrome is a condition well established in
nowadays, and it is associated with the promotion of
atherosclerosis and increase of the cardiovascular risk.
Moreover, there is extensive scientific evidence, especially
in countries with better and long lasting national health
programs, that the prevalence of metabolic syndrome has
increased in the last decade, which suggest that the disease
burden (including type 2 diabetes) has increased as well
[1]. Despite its multiple origins, obesity, sedentary life
coupled with unhealthy diet and genetic factors interact to
produce this syndrome. ATP III raised the significance of
diagnosing and treating the metabolic syndrome, focus-
ing on physical activity, lowering excess body fat and on
specific dietary patterns. During the past years several ep-
idemiological studies have underlined the relation be-
tween diet and incidence of coronary heart disease, and
other diseases [16–18]. Dietary factors exert their influ-
ence largely through their effects on blood lipids and lipo-
proteins, as well as on the other established modifiable
risk factors, with the exception of cigarette smoking. Our
findings support the hypothesis that adoption of Mediter-
ranean diet by subjects who met the criteria for the meta-
bolic syndrome is associated with a significant reduction
of the risk of developing acute coronary events. The inves-
tigated type of diet is low in saturated fat, high in mo-
nounsaturated fat, mainly from olive oil, high in complex
carbohydrates, from legumes, and high in fibre, mostly
from vegetables and fruits. Also, epidemiological studies
suggest that the Mediterranean diet is associated with low-
er coronary heart disease risk, especially through the re-
duction of blood pressures, body mass index, and levels of
several thrombogenic factors [12,13,18,19]. Recently, the
findings from the Lyon Diet Heart study illustrate the po-
tential importance of the Mediterranean dietary pattern,
especially when compared to other recommended diets,
like Step-I diet [19]. Also, results from a Spanish Study
suggest that the monounsaturated fatty acids diets are
associated with a significant reduction and a better con-
trol of both systolic and diastolic blood pressure [20].
However it still remains a matter of debate if the protec-
tive influence is primarily caused by single nutrients, e.g.
dietary fatty acids, potassium or dietary fibre or if it can be
attributed to the Mediterranean diet as a whole [12].
EUROASPIRE Study group investigators suggest to the car-
diologists, physicians and public health policy makers to
moderate the prevalence of the cardiovascular risk factors
Table 2: Results from the multivariate analysis that was developed to evaluate the coronary risk (odds ratio; 95% confidence interval) 
in subjects with the metabolic syndrome
Odds ratio 95% Confidence interval
Adoption of Mediterranean diet (yes vs. no) 0.77 0.645 – 0.918
Age of participants (1-year) 1.03 1.004 – 1.054
Male sex 2.02 1.079 – 3.787
Hypercholesterolemia (presence vs. absence) 6.00 3.720 – 9.686
Family history of CHD (yes vs. no) 5.16 3.016 – 8.837
Low vs. high income 1.69 1.166 – 2.392
Diabetes mellitus (presence vs. absence) 1.67 1.072 – 2.925
Current smoking habits (yes vs. no) 2.40 1.522 – 3.790
Physical activity vs. sedentary 0.89 0.839 – 0.945
Obesity (presence vs. absence) 1.05 0.641 – 1.312Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/1
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in order to further reduce coronary heart disease morbid-
ity and mortality and improve patient's chances of surviv-
al [21]. This reduction may be achieved through the
adoption of a healthier lifestyle, including stopping smok-
ing, initiation of physical activities and adoption of a
healthy diet. Recently the NCEP ATP III recommended for
Therapeutic Lifestyle Changes [2] in order to reduce the
prevalence of the metabolic syndrome among popula-
tions. These changes underlined the importance of low-
saturated diet consumption (<7% of total fat) and physi-
cal exercise. In our work we found that the adoption of
Mediterranean diet seems to be associated with a consid-
erable reduction of acute coronary events (i.e. 30%) in
people with the metabolic syndrome. Interestingly, is that
the adoption of Mediterranean diet by physically active
people is associated with much higher reduction of the
odds of developing acute coronary event, than diet or ex-
ercise achieve alone. A plausible explanation could be the
low concentration of this type of diet in saturated fat and
the non-lipid-lowering benefits that physical activities
and Mediterranean diet have been reported to produce
(including antithrombotic and anti-inflammatory effects)
[22,23]. In accordance to that, several investigators have
reported that non-pharmacological lifestyle interventions,
like diet and exercise, could be useful in the management
of hypertensive subjects [24,25].
This is the first study concerning the prevalence of the
metabolic syndrome in Greece and the effect of the Medi-
terranean diet on the related coronary risk. The results of
our study suggest that one third of the acute coronary
events could be prevented by the adoption of the Mediter-
ranean diet in subjects with the metabolic syndrome. Ed-
ucation and training will be critical to ensure that
physicians have knowledge to diagnose and treat patients
with the metabolic syndrome. So the early identification,
treatment (with non pharmacological interventions) and
prevention of the metabolic syndrome seems to be ex-
tremely challenging and provoking for the health policy
makers, in order to reduce the epidemic of overweight,
improper nutrition and sedentary lifestyle. However, even
the observed association is independent from several po-
tential confounders it is hard to claim that our findings
suggest causal evidence and much remains to be learned
about this "ecological" effect on coronary risk in people
with the metabolic syndrome.
Limitations of the study
In retrospective case-control studies, two main sources of
systematic errors may exist, the selection and the recall bi-
as. In order to eliminate selection bias we tried to set ob-
jective criteria, both for patients and controls. However,
insignificant misclassification may exist, since a small per-
centage of asymptomatic coronary patients may be
wrongly assigned to controls, even if they were evaluated
by a cardiologist. Also, in case-control studies, it is usually
observed that patients who had a recent adverse event are
more likely to place greater emphasis (overestimate) on
several factors related to the disease than the control
group (recall bias). In order to reduce this type of bias and
analyze accurate information we made an effort to obtain
accurate information from the patients as well as from
their relatives or their accompanying persons. However,
overestimation of the effect of the investigated combina-
tion may still exist. Concerning the medical information,
we tried to avoid recall bias by obtaining accurate and de-
tailed data from subjects medical records. However, over/
under estimation may still exist, especially in the measure-
ment of nutritional and smoking habits, and the onset of
the investigated cardiovascular risk factors. Moreover, the
coronary patients who died at entry or the day after were
not included in the study. This bias could influence our re-
sults, but, since the proportion of deaths during the first
two days was estimated between 2–4%, we believe that
the inability to include the fatal events did not alter signif-
icantly our findings. Furthermore, regarding the potential
effect of uncontrolled – unknown confounders, we tried
to reduce it using the same study base, both for patients
and controls.
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